# Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects

> **NCT01247103** · PHASE1 · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 128 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AZD4316
- **DRUG:** AZD4316
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01247103
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247103, "Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01247103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*